Stallergenes Greer Foundation Science Awards for Allergy 2023: Call for Applications
The Stallergenes Greer Foundation aims to create healthier futures for all. The Foundation, under the aegis of the Fondation de France, is philanthropically dedicated to three focus areas:
- Advancing scientific research to bolster innovation and precision medicine.
- Supporting academic initiatives to further develop future generations of allergy healthcare professionals.
- Engaging in climate action and environmental protection to progress the prevention and treatment of allergies.
Submissions are open for the Stallergenes Greer Foundation Science Awards for Allergy 2023. A total of €150,000 will be awarded for outstanding work led either by a young scientist or a mid-career scientist to advance precision medicine in the field of allergy, or outstanding work in the environmental field to advance the prevention and treatment of allergies.
The Stallergenes Greer Foundation Science Awards for Allergy are presented in two areas:
- Innovation Awards: two awards will be presented either to encourage and raise the profile of a young scientist (below 40 years of age) or to recognise the outstanding work of a mid-career scientist (with a 10–20-year track record), who are driving innovation in respiratory and food allergy.
- Environmental Health Award: the award will honour the work of a researcher who is pioneering research aimed at preserving and restoring both natural and built ecosystems and contributing to advancing the prevention and treatment of allergies.
Timeline: The submission period is open from July 1, 2023, to November 29, 2023, at 11:59pm CET. Submissions will be reviewed by the Stallergenes Greer Foundation’s Board of Trustees. Decision letters will be sent out at the end of February 2024.
Eligibility: the awards are open to physicians, PhDs and Pharm-Ds actively engaged in allergy research and attached to a research team in a non-profit research laboratory. There are no geographic limitations.
Rules and regulations: Detailed guidelines regarding the Stallergenes Greer Foundation’s Science Awards for Allergy are available on the foundation’s website: https://stallergenesgreer-foundation.org
About the Stallergenes Greer Foundation
The Stallergenes Greer Foundation, under the aegis of the Fondation de France, is a non-profit foundation whose aim is to build healthier futures for all. The Stallergenes Greer Foundation pursues a comprehensive approach calling for “the collaborative efforts of multiple disciplines working locally, nationally, and globally, to attain optimal health for people, animals and our environment”, as defined by the One Health initiative.
About the Fondation de France
Created in 1969, Fondation de France is a private organisation recognised of public interest, whose mission is to support all forms of generosity and translate them into effective actions of general interest. With close to 1,000 hosted foundations, the Fondation de France supports more than 10,000 promising and innovative initiatives each year, in France and abroad. Independent and private, it operates thanks to the generosity of donors.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005058/en/
Contact information
Stallergenes Greer Foundation
Catherine Kress
Secretary General
Tel: +33 (0)1 55 50 26 05
Email: catherine.kress@stallergenesgreer.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aptiv Powers Intelligent Edge Applications From Automotive to Robotics at CES 20265.1.2026 08:01:00 EET | Press release
Aptiv PLC (NYSE: APTV),a global industrial technology company, will showcase at CES 2026 how its intelligent edge solutions enable devices to sense, think, and act in real time—while continuously optimizing performance throughout their lifecycle. This approach brings advanced computing and artificial intelligence closer to where data is generated, unlocking AI-driven solutions for transportation, robotics, aerospace, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260104888341/en/ Aptiv Powers the Intelligent Edge from Automotive to Robotics at CES 2026 By processing data locally at the edge, rather than relying solely on centralized cloud systems, Aptiv’s solutions enable faster response time and greater optimization at a system level. “At CES 2026, we’re demonstrating how Aptiv enables real-time perception, decision-making, and actuation—transforming how vehicles and other intelligent, connected devices deliver
Belkin Unveils Next-Generation Chargers, Gaming Power Accessories and More at CES 20264.1.2026 19:00:00 EET | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced a bold new lineup of accessories designed to power, protect, and enhance the way people work, play, and connect. The new collection, debuting at CES 2026, includes advanced power banks, Qi2 25W wireless chargers, a wireless HDMI dongle for seamless content sharing, and a next gen charging case for the Nintendo Switch 2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260104976028/en/ Belkin unveils new products at CES 2026 Gaming Charging Case Pro for Nintendo Switch 2 (Model ENA003) Engineered for the ultimate on-the-go gaming experience, the Pro case delivers power, protection, and portability in one premium package. A removable 10,000 mAh power bank delivers up to 30W fast charging and features an LCD screen to display remaining battery life. The Pro version builds on the standard model’s safe in‑case charging with a sleeker, integrated power b
Belkin Elevates Everyday Device Protection with a New Lineup of Screen Protectors and a Wear & Tear Program4.1.2026 19:00:00 EET | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announces a new class of screen protection solutions, a strategic partnership, and an all-new wear-and-tear program; advancing its commitment to keeping devices protected and consumers confident. The launch includes seven new screen protectors, a customization partnership with ScreenSkinz, and a screen protection replacement program designed to give users lasting peace of mind and ensure the products they love stay safe, secure, and in the best shape. Meet the ScreenForce Titan Lineup: The Ultimate in Full-Screen Protection Titan SmartShield Titan SmartShield serves as the premium rigid protector in the lineup, delivering aerospace-grade impact resistance and up to 18x the strength of traditional glass*. Engineered with a 9H surface hardness and rated for up to 6.5 ft / 2 m of drop protection**, Titan SmartShield offers exceptional durability without compromising clarity. An advanced anti-reflective coating preserves
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement4.1.2026 17:13:00 EET | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order governing the Company’s board composition and corporate actions pending trial, and announced the engagement of Zhonghua Certified Public Accountants LLP (“Zhonghua”), an affiliate of the global accounting network UHY International, as the Company’s independent auditor and registered public accounting firm. Update on Antigua High Court Order Further to the order issued by the Antigua High Court (the “Court”) previously disclosed by the Company in a press release dated December 17, 2025, the Court has updated its order to provide that directors Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Dr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y. Yan and Mr. Weidong Yin (collectively, the “Board”), will comprise the Board of the Company until the trial liste
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report4.1.2026 17:00:00 EET | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq’s Listing Rule 5250(c)(2) since the Company did not timely file a Form 6-K containing an interim balance sheet and income statement as of the end of its second quarter of year 2025. As previously disclosed, the Company received a delisting determination letter (the “Staff Determination”) from Nasdaq in November 2025. The Company requested a hearing before the Nasdaq Hearings Panel to appeal the Staff Determination on November 19, 2025. Nasdaq has informed the Company that the Nasdaq Hearings Panel will also consider the matter addressed in the Notification Letter at a hearing scheduled for January 8, 2026 at which the Company has been invited to present
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom